Skip to content

Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury

Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury - A Randomized Controlled Prospective Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03996525
Enrollment
7
Registered
2019-06-24
Start date
2019-09-16
Completion date
2022-10-03
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell Palsy, Hemifacial Paralysis

Keywords

unilateral facial nerve palsy, facial nerve palsy, facial palsy, facial paralysis, cross facial nerve graft, CFNG, peripheral nerve stimulation, electrical stimulation, e-stim, free muscle transfer, FMT

Brief summary

After nerve injury and facial palsy, many patients have permanent muscle and sensory dysfunction. Electrical stimulation (ES) of injured nerves may speed up axon growth and improve recovery. This study will assess if ES accelerates motor axon regeneration and improves muscle recovery in patients undergoing two-staged facial reanimation for facial palsy. This study of ES in these patients will investigate: i) nerve regeneration over long distances; ii) direct evidence of changes in nerve regeneration with nerve samples from the second procedure; and iii) changes in functional outcomes in a patient population with much less variability. Our study will provide evidence about the effect of ES in improving outcomes in patients with nerve injuries.

Interventions

DEVICEElectrical Stimulation

Two-Stage Facial Reanimation (Standard Practice) with electrical stimulation for one hour at 20Hz (Experimental Procedure). 1. Cross-Facial Nerve Graft (CFNG) immediately followed by electrical nerve stimulation proximal to the coaptation site on the donor facial nerve. 2. Nine-to-Twelve Months later, Free Muscle Transfer (FMT) followed by electrical nerve stimulation proximal to the coaptation site in the intraoral incision.

DEVICESham Treatment

Two-Stage Facial Reanimation (Standard Practice) with sham electrical stimulation for one hour (Placebo). 1. Cross-Facial Nerve Graft (CFNG) followed by placement of unelectrified electrodes proximal to the coaptation site on the donor facial nerve. 2. Free Muscle Transfer (FMT) followed by placement of unelectrified electrodes proximal to the coaptation site in the intraoral incision.

Sponsors

The Physicians' Services Incorporated Foundation
CollaboratorOTHER
The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

Patients undergoing unilateral facial reanimation with a two-stage cross-face nerve graft and free gracilis muscle flap transfer who have; * i) isolated unilateral facial nerve palsy and * ii) a functioning contralateral facial nerve.

Exclusion criteria

* Any disorders that may compromise nerve regeneration or muscle function following muscle transfer, including diabetes, polyneuropathy, or myopathy and muscular dystrophy. * Patients with severe cognitive impairment, which would limit their participation

Design outcomes

Primary

MeasureTime frameDescription
Change in Pre-Operative Lip Excursion with SmileChange from Baseline (Pre-Op) over 2 YearsFACEGRAM will be used to objectively analyse change in commissure excursion.
Change in Myelinated Axon CountChange from Baseline (Pre-Op) to the Final Surgery 1 Year LaterThe number of myelinated nerve fibres that regenerate and reach the distal CFNG will be compared between groups.

Secondary

MeasureTime frameDescription
Time to ReinnervationUp to 1 year after the Second Operation (FMT)Study participants are requested to monitor their facial movements and record any changes in a daily diary once they first notice facial movement.
Myelin ThicknessChange from Baseline (Pre-Op) to the Final Surgery 1 Year LaterUsing histomorphometry, Myelin Thickness will be used as a surrogate measure for the rate of axon regeneration.
Change in Facial SymmetryChange from Baseline (Pre-Op) over 2 YearsFACEGRAM will be used to objectively analyse smile symmetry.
Myelin Thickness/Fibre Diameter RatioChange from Baseline (Pre-Op) to the Final Surgery 1 Year LaterUsing histomorphometry, Myelin Thickness/Fibre Diameter Ratio will be used as a surrogate measure for the rate of axon regeneration.
Nerve Fibre DiameterChange from Baseline (Pre-Op) to the Final Surgery 1 Year LaterUsing histomorphometry, Nerve Fibre Diameter will be used as a surrogate measure for the rate of axon regeneration.
Facial Clinimetric Evaluation (FaCE) ScoresChange from Baseline (Pre-Op) Over 2 YearsThe Facial Clinimetric Evaluation (FaCE) Scale is a patient-report questionnaire assessing facial impairment and disability associated with facial paralysis. The 15-item likert scale questionnaire consists of six domains: i) facial movement, ii) facial comfort, iii) oral function, iv) eye comfort, v) lacrimal control and vi) social function. Each domain produces its own score, with 1 meaning 'problems all the time' and 5 suggesting 'no problems at all.' The domain scores can then be summed to produce a total score assessing total quality of life with respect to facial paralysis.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026